Long‐term disease control and safety with the anti‐CCR4 antibody mogamulizumab: Post‐hoc analyses from the MAVORIC trial of patients with previously treated cutaneous T‐cell lymphoma. Issue 8 (28th June 2022)

Record Type:: Journal Article
Title:: Long‐term disease control and safety with the anti‐CCR4 antibody mogamulizumab: Post‐hoc analyses from the MAVORIC trial of patients with previously treated cutaneous T‐cell lymphoma. Issue 8 (28th June 2022)
Main Title:: Long‐term disease control and safety with the anti‐CCR4 antibody mogamulizumab: Post‐hoc analyses from the MAVORIC trial of patients with previously treated cutaneous T‐cell lymphoma
Authors:: Bagot, Martine
Dalle, Stéphane
Sokol, Lubomir
Tsianakas, Athansios
Musiek, Amy
Ortiz‐Romero, Pablo L.
Poligone, Brian
Duvic, Madeleine
Elmets, Craig
Leoni, Mollie
Dwyer, Karen
Ito, Takahiro
Herr, Fiona
Kim, Youn H.
Abstract:
Is Part Of:: Dermatologic therapy. Volume 35:Issue 8(2022)
Journal:: Dermatologic therapy
Issue:: Volume 35:Issue 8(2022)
Issue Display:: Volume 35, Issue 8 (2022)
Year:: 2022
Volume:: 35
Issue:: 8
Issue Sort Value:: 2022-0035-0008-0000
Page Start:: n/a
Page End:: n/a
Publication Date:: 2022-06-28
Subjects:: Skin -- Diseases -- Periodicals
Dermatology -- Periodicals
616.5
Journal URLs:: http://firstsearch.oclc.org ↗
http://firstsearch.oclc.org/journal=1396-0296;screen=info;ECOIP ↗
http://onlinelibrary.wiley.com/journal/10.1111/%28ISSN%291529-8019 ↗
http://www.blackwell-synergy.com/member/institutions/issuelist.asp?journal=dth ↗
http://onlinelibrary.wiley.com/ ↗
DOI:: 10.1111/dth.15634 ↗
Languages:: English
ISSNs:: 1396-0296
Deposit Type:: Legaldeposit
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗
Physical Locations:: British Library DSC - 3555.143000
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store
Ingest File:: 23061.xml